Literature DB >> 26018987

Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging.

Hunter R Underhill1,2, Katie Golden-Grant3, Lauren T Garrett3, Stefanie Uhrich3, Brandon A Zielinski4, C Ronald Scott3.   

Abstract

BACKGROUND: To identify quantitative MRI parameters associated with diffusion tensor imaging (DTI) and fast bound-pool fraction imaging (FBFI) that may detect alterations in gray matter and/or white matter in adults with Fabry disease, a lysosomal storage disorder.
MATERIALS AND METHODS: Twelve healthy controls (mean age ± standard deviation: 48.0 ± 12.4 years) and 10 participants with Fabry disease (46.7 ± 12.9 years) were imaged at 3.0 Tesla. Whole-brain parametric maps of diffusion tensor metrics (apparent diffusion coefficient [ADC] and fractional anisotropy [FA]) and the bound-pool fraction (f) were acquired. Mean voxel values of parametric maps from regions-of-interest within gray and white matter structures were compared between cases and controls using the independent t-test. Spearman's rho was used to identify associations between parametric maps and age.
RESULTS: Compared with controls, the left thalamus of Fabry participants had an increase in FA (0.29 ± 0.02 versus 0.33 ± 0.05, respectively; P = 0.030) and a trend toward an increase in ADC (0.73 ± 00.02 versus 0.76 ± 0.03 μm(2) /s, respectively; P = 0.082). The left posterior white matter demonstrated a reduction in f (10.45 ± 0.37 versus 9.00 ± 1.84%, respectively; P = 0.035), an increase in ADC (0.78 ± 0.04 versus 0.94 ± 0.19 μm(2) /s, respectively; P = 0.024), and a trend toward a reduction in FA (0.42 ± 0.07 versus 0.36 ± 0.08, respectively; P = 0.052). Among all parameters, only f measured in the left posterior white matter was significantly associated with age in Fabry participants (rho = -0.71; P = 0.022).
CONCLUSION: Parameters derived from DTI and FBFI detect Fabry-related changes in the adult human brain, particularly in the posterior white matter where reductions in myelin density as measured by FBFI appear age related.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fabry disease; bound-pool fraction; diffusion tensor imaging; magnetization transfer; quantitative MRI; white matter disease

Mesh:

Year:  2015        PMID: 26018987      PMCID: PMC4662657          DOI: 10.1002/jmri.24952

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  35 in total

1.  Direct quantitative comparison between cross-relaxation imaging and diffusion tensor imaging of the human brain at 3.0 T.

Authors:  Hunter R Underhill; Chun Yuan; Vasily L Yarnykh
Journal:  Neuroimage       Date:  2009-06-13       Impact factor: 6.556

2.  Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI.

Authors:  J G Sled; G B Pike
Journal:  Magn Reson Med       Date:  2001-11       Impact factor: 4.668

3.  Elevated CNS average diffusion constant in Fabry disease.

Authors:  D F Moore; R Schiffmann; A M Ulug
Journal:  Acta Paediatr Suppl       Date:  2002

4.  The pulvinar sign: frequency and clinical correlations in Fabry disease.

Authors:  Alessandro P Burlina; Renzo Manara; Catherine Caillaud; Jean-Pierre Laissy; Mariasavina Severino; Isabelle Klein; Alberto Burlina; Olivier Lidove
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

5.  Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study.

Authors:  S Buechner; M Moretti; A P Burlina; G Cei; R Manara; R Ricci; R Mignani; R Parini; R Di Vito; G P Giordano; P Simonelli; G Siciliano; W Borsini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-06-05       Impact factor: 10.154

6.  T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease.

Authors:  Jun-ichi Takanashi; A James Barkovich; William P Dillon; Elliott H Sherr; Kimberly A Hart; Seymour Packman
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

7.  An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia.

Authors:  Riki Okeda; Masahiro Nisihara
Journal:  Neuropathology       Date:  2008-04-11       Impact factor: 1.906

8.  Voxel based analyses of diffusion tensor imaging in Fabry disease.

Authors:  J Albrecht; P R Dellani; M J Müller; I Schermuly; M Beck; P Stoeter; A Gerhard; A Fellgiebel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

9.  Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.

Authors:  C Ronald Scott; Susan Elliott; Norman Buroker; Lauren I Thomas; Joan Keutzer; Michael Glass; Michael H Gelb; Frantisek Turecek
Journal:  J Pediatr       Date:  2013-03-01       Impact factor: 4.406

10.  Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry.

Authors:  Katherine Sims; Juan Politei; Maryam Banikazemi; Philip Lee
Journal:  Stroke       Date:  2009-01-15       Impact factor: 7.914

View more
  5 in total

1.  Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

Authors:  Sirio Cocozza; Gaia Olivo; Eleonora Riccio; Camilla Russo; Giuseppe Pontillo; Lorenzo Ugga; Silvia Migliaccio; Dario de Rosa; Sandro Feriozzi; Massimiliano Veroux; Yuri Battaglia; Daniela Concolino; Federico Pieruzzi; Antonino Tuttolomondo; Aurelio Caronia; Cinzia Valeria Russo; Roberta Lanzillo; Vincenzo Brescia Morra; Massimo Imbriaco; Arturo Brunetti; Enrico Tedeschi; Antonio Pisani
Journal:  Neuroradiology       Date:  2017-04-06       Impact factor: 2.804

Review 2.  Biomarkers and Imaging Findings of Anderson-Fabry Disease-What We Know Now.

Authors:  Idalina Beirão; Ana Cabrita; Márcia Torres; Fernando Silva; Patrício Aguiar; Francisco Laranjeira; Ana Marta Gomes
Journal:  Diseases       Date:  2017-06-11

Review 3.  Neuroimaging in Fabry disease: current knowledge and future directions.

Authors:  Sirio Cocozza; Camilla Russo; Giuseppe Pontillo; Antonio Pisani; Arturo Brunetti
Journal:  Insights Imaging       Date:  2018-11-02

Review 4.  Macromolecular Proton Fraction as a Myelin Biomarker: Principles, Validation, and Applications.

Authors:  Alena A Kisel; Anna V Naumova; Vasily L Yarnykh
Journal:  Front Neurosci       Date:  2022-02-09       Impact factor: 5.152

5.  Altered Gene Expression in Prefrontal Cortex of a Fabry Disease Mouse Model.

Authors:  Kai K Kummer; Theodora Kalpachidou; Miodrag Mitrić; Michiel Langeslag; Michaela Kress
Journal:  Front Mol Neurosci       Date:  2018-06-25       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.